Michael A Tortorici

US Patent:

20200055922, Feb 20, 2020

Filed:

Apr 20, 2018

Appl. No.:

16/606605

Inventors:

- BERN, CH
JOHN-PHILIP LAWO - SCHWANEWEDE, DE
BILLIE DURN - FUQUAY-VARINA NC, US
MICHAEL TORTORICI - BERWYN PA, US
OTHMAR ZENKER - WEIMAR, DE
IVO VAN SCHAIK - AMSTELVEEN, NL

Assignee:

CSL BEHRING AG - BERN

International Classification:

C07K 16/06
A61P 25/00

Abstract:

The present invention relates to immunoglobulin products for use in the treatment of chronic inflammatory demyelinating polyneuropathy using immunoglobulin products. In particular, the present invention provides efficacious dosing regimens.

US Patent:

20190183991, Jun 20, 2019

Filed:

Aug 23, 2017

Appl. No.:

16/327553

Inventors:

- Marburg, DE
Dipti PAWASKAR - Philadelphia PA, US
Michael TORTORICI - Berwyn PA, US
Ingo PRAGST - Edertal, DE
Ying ZHANG - Chesterbrook PA, US

International Classification:

A61K 38/57
A61P 7/10
A61K 9/00
G01N 33/68
G16H 20/10

Abstract:

The invention relates to a method for determining a dosing scheme for the treatment of hereditary angioedema and/or the prevention of hereditary angioedema attacks with C1 esterase inhibitor to optimize treatment response in an individual patient. Accordingly, the present invention provides means for determining individual C1 esterase inhibitor dosing schemes that result in an optimal treatment/prevention outcome.